Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Atassi

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Investigational New Drugs|September 1, 1988
Preclinical antitumor activity of batracylin (NSC 320846)J Plowman, K D Paull, G Atassi, et al.
Molecular Pharmacology|November 28, 2001
Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosisS Léonce, V Pérez, S Lambel, et al.
Cancer Research|July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agentJ A Hickman, M F Stevens, N W Gibson, et al.
Journal of Medicinal Chemistry|July 22, 1994
Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N- [(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivativesR Jasztold-Howorko, C Landras, A Pierré, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
In vivo antitumor activity of S 16020-2, a new olivacine derivativeN Guilbaud, L Kraus-Berthier, D Saint-Dizier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitorsA M Chollet, T Le Diguarher, L Murray, et al.
Journal of the National Cancer Institute|September 21, 1988
Intraperitoneal chemotherapy with cisplatin and melphalanM J Piccart, J Abrams, P F Dodion, et al.
Investigational New Drugs|August 1, 1992
In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivativeA Pierré, T A Dunn, L Kraus-Berthier, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 13, 2001
From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitorsJ M Henlin, J A Boutin, N Kucharczyk, et al.
Journal of Medicinal Chemistry|July 6, 2000
Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycineN Costes, H Le Deit, S Michel, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Investigational New Drugs|September 1, 1988
Preclinical antitumor activity of batracylin (NSC 320846)J Plowman, K D Paull, G Atassi, et al.
Molecular Pharmacology|November 28, 2001
Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosisS Léonce, V Pérez, S Lambel, et al.
Cancer Research|July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agentJ A Hickman, M F Stevens, N W Gibson, et al.
Journal of Medicinal Chemistry|July 22, 1994
Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N- [(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivativesR Jasztold-Howorko, C Landras, A Pierré, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
In vivo antitumor activity of S 16020-2, a new olivacine derivativeN Guilbaud, L Kraus-Berthier, D Saint-Dizier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitorsA M Chollet, T Le Diguarher, L Murray, et al.
Journal of the National Cancer Institute|September 21, 1988
Intraperitoneal chemotherapy with cisplatin and melphalanM J Piccart, J Abrams, P F Dodion, et al.
Investigational New Drugs|August 1, 1992
In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivativeA Pierré, T A Dunn, L Kraus-Berthier, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 13, 2001
From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitorsJ M Henlin, J A Boutin, N Kucharczyk, et al.
Journal of Medicinal Chemistry|July 6, 2000
Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycineN Costes, H Le Deit, S Michel, et al.
Pageof 19